ARK Genomic Revolution ETF logo

ARK Genomic Revolution ETF

ETF
ETF
Ticker: ARKG
ARKG

Price

Price

CHART BY

Data

TER

 
0.75%

Fund Volume

 
$1.34B

Asset Class

 
Equity

Distributing

 
Yes

Replication Method

 
Physical Full

Region

 
Global

Country Based

 
USA

Issuer

 
ARK

Historical dividends and forecast

All dividend data

 


$0.55

CHART BY

Industry Breakdown

  • Biotechnology
    45.77%
  • Medical Specialties
    19.76%
  • Packaged Software
    12.91%
  • Medical/ Nursing Services
    12.63%
  • Major Pharmaceuticals
    8.88%
  • Not Classified
    0.05%

Sector Breakdown

  • Health Care
    99.95%
  • Other
    0.05%

Region Breakdown

  • 🇺🇸

    USA
    90.13%
  • 🇨🇭

    Switzerland
    7.85%
  • 🇬🇧

    United Kingdom
    1.01%
  • 🇳🇱

    Netherlands
    0.97%
  • 🏳️

    Other
    0.05%

Frequently asked questions

What is the Total Expense Ratio (TER) of ARK Genomic Revolution ETF?

The total expense ratio (TER) of ARK Genomic Revolution ETF is 0.75%. The TER represents the annual fees charged by the ETF provider, covering management costs and operational expenses. A lower TER can enhance your investment returns over time.

What is the fund volume of ARK Genomic Revolution ETF?

ARK Genomic Revolution ETF has a fund volume of $1.34B. Fund volume indicates the total assets under management (AUM) and reflects the ETF's size and liquidity. Larger fund volumes generally offer better liquidity and tighter bid-ask spreads.

Is ARK Genomic Revolution ETF paying dividends?

ARK Genomic Revolution ETF is a Distributing ETF. It distributes dividends to investors. The last payment was 31.12.2021, with an amount of $0.38.

What is the replication method used by ARK Genomic Revolution ETF?

ARK Genomic Revolution ETF uses a physical full replication method. In this approach, the ETF purchases all the securities in the underlying index in the exact proportions as the index. This ensures the most precise tracking of the index's performance since the ETF's holdings mirror the index completely.

In which country is ARK Genomic Revolution ETF domiciled?

ARK Genomic Revolution ETF is domiciled in USA. The domicile country can affect tax implications and regulatory oversight, which may influence your investment decisions.

Pricing

1D span
$30.79$32.01
52W span
$17.55$34.05

Information

ARKG is an actively managed fund that targets companies involved in the genomics industry.

Identifier

Primary Ticker
ARKG

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation